Ilan Leibovitch

4.4k total citations · 1 hit paper
117 papers, 3.1k citations indexed

About

Ilan Leibovitch is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ilan Leibovitch has authored 117 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Surgery, 28 papers in Molecular Biology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ilan Leibovitch's work include Testicular diseases and treatments (23 papers), Bladder and Urothelial Cancer Treatments (22 papers) and Urological Disorders and Treatments (18 papers). Ilan Leibovitch is often cited by papers focused on Testicular diseases and treatments (23 papers), Bladder and Urothelial Cancer Treatments (22 papers) and Urological Disorders and Treatments (18 papers). Ilan Leibovitch collaborates with scholars based in Israel, United States and Netherlands. Ilan Leibovitch's co-authors include Yoram Mor, Jacob Ramon, Jacob Golomb, Eyal Mishani, Einat Even‐Sapir, Ur Metser, Hedva Lerman, Gennady Lievshitz, John P. Donohue and Richard S. Foster and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Nanoscale.

In The Last Decade

Ilan Leibovitch

114 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.

2006 589 citations Ilan Leibovitch et al. profile →

Peers

Countries citing papers authored by Ilan Leibovitch

Since Specialization

Citations

This map shows the geographic impact of Ilan Leibovitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilan Leibovitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilan Leibovitch more than expected).

Fields of papers citing papers by Ilan Leibovitch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilan Leibovitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilan Leibovitch. The network helps show where Ilan Leibovitch may publish in the future.

Co-authorship network of co-authors of Ilan Leibovitch

This figure shows the co-authorship network connecting the top 25 collaborators of Ilan Leibovitch. A scholar is included among the top collaborators of Ilan Leibovitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilan Leibovitch. Ilan Leibovitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Novel Modality Enables New Evidence-Based Individual Risk Stratification That Can Potentially Lead to Decisive Management and Treatment Decisions in Prostate Cancer 2023 ·Diagnostics ·(unknown), (unknown), Robert E. Lenkinski, H. Landsman, Haim Matzkin, Nicola J. Mabjeesh, Ilan Leibovitch	2
2	Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study 2023 ·Nutrients ·Daniel Keizman, Moshe Frenkel, Avivit Peer, Eli Rosenbaum, David Sarid, Ilan Leibovitch, Roy Mano, Ofer Yossepowitch, Ido Wolf, Ravit Geva, David Margel, Keren Rouvinov, Anat Stern, (unknown), Igal Kushnir, Isaac Eliaz	6
3	P-MCP treatment in non-metastatic biochemically relapsed prostate cancer (BRPC-M0): Final long-term results of a prospective phase II study. 2023 ·Journal of Clinical Oncology ·Daniel Keizman, Moshe Frenkel, Avivit Peer, Igal Kushnir, Eli Rosenbaum, David Sarid, Ilan Leibovitch, (unknown), Ofer Yossepowitch, David Margel, Ido Wolf, (unknown), Keren Rouvinov, (unknown), Isaac Eliaz	1
4	A comparison between 68Ga-labeled prostate-specific membrane antigen-PET/CT and multiparametric MRI for excluding regional metastases prior to radical prostatectomy 2020 ·Abdominal Radiology ·(unknown), (unknown), (unknown), (unknown), Itay Sternberg, Ilan Leibovitch, Yoram Dekel, Gilad E. Amiel, Amnon Zisman, Jack Baniel, Miki Haifler, (unknown), (unknown), (unknown), Barak Rosenzweig, (unknown), Shay Golan	11
5	Assessing the Safety and Efficacy of the ClearRing™ Implant for the Treatment of Benign Prostatic Hyperplasia in a Canine Model 2018 ·Current Urology ·Yair Feld, (unknown), Ilan Leibovitch	6
6	First-in-man Safety and Efficacy of the ClearRing Implant for the Treatment of Benign Prostatic Hyperplasia 2018 ·European Urology Focus ·Egils Vjaters, (unknown), Michael Mullerad, Dov Engelstein, Ilan Leibovitch, Yair Feld	9
7	Attenuation of encrustation by self-assembled inorganic fullerene-like nanoparticles 2014 ·Nanoscale ·(unknown), David Zbaida, (unknown), Rita Rosentsveig, Ilan Leibovitch, Reshef Tenne	14
8	The Role of a Combined Regimen With Intravesical Chemotherapy and Hyperthermia in the Management of Non-muscle-invasive Bladder Cancer: A Systematic Review 2011 ·European Urology ·Rianne J.M. Lammers, J. Alfred Witjes, Brant A. Inman, Ilan Leibovitch, Menachem Laufer, Ofer Nativ, Renzo Colombo	147
9	The clinical significance of class III (suspicious) urine cytology 2010 ·Cytopathology ·Itay Sternberg, (unknown), (unknown), S. Lew, Ilan Leibovitch	12
10	Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts 2008 ·The Prostate ·Lilach Agemy, Alon Harmelin, Tova Waks, Ilan Leibovitch, (unknown), M. Raphael Pfeffer, Zelig Eshhar	15
11	Fascial patch technique for repair of complicated urethrovaginal fistula 2006 ·Urology ·Jacob Golomb, Ilan Leibovitch, Yoram Mor, Andrei Nadu, Jacob Ramon	5
12	The Vicious Cycling: Bicycling Related Urogenital Disorders 2004 ·European Urology ·Ilan Leibovitch, Yoram Mor	131
13	Pulmonary embolism—the initial manifestation of renal cell carcinoma in a young woman 2003 ·Emergency Radiology ·Gabriela Gayer, (unknown), David Olchovsky, Ilan Leibovitch, Sara Apter, Rony Weitzen, M. Hertz	5
14	Ureteral substitution using the isolated interposed vermiform appendix in a patient with a single kidney and transitional cell carcinoma of the ureter 1994 ·Urology ·(unknown), Ilan Leibovitch, Itamar Avigad	17
15	Symptomatic Heterotopic Splenic Tissue in the Left Renal Fossa 1994 ·European Urology ·(unknown), Ilan Leibovitch, Sara Apter, Yoram Mor, Benad Goldwasser	11
16	Hematuria and VoidingDisorders in Children Caused byCongenital Urethral Polyps 1993 ·European Urology ·Gil Raviv, Ilan Leibovitch, (unknown), M. Hertz, Benad Goldwasser, P. Jonas	9
17	Quantitative Changes inPlatelet Counts following MajorUrological Pelvic Surgery 1993 ·European Urology ·Ilan Leibovitch, (unknown), Yoram Mor, Itamar Avigad, (unknown), Gil Raviv	10
18	Etiology of Acute Scrotum at Surgical Exploration in Children, Adolescents and Adults 1992 ·European Urology ·Benad Goldwasser, Jacob Ben‐Chaim, Ilan Leibovitch, Jacob Ramon, (unknown)	33
19	Sulfated Glycoprotein‐2 Induced Endogenous Resistance to Ischemia and Reperfusion Injury in the Seminiferous Tubules 1991 ·American Journal of Reproductive Immunology ·Ilan Leibovitch, Ralph Buttyan	9
20	Increased serum alkaline phosphatase activity: A possible indicator of renal damage 1991 ·Journal of Clinical Laboratory Analysis ·Ilan Leibovitch, Jacob Ben‐Chaim, Jacob Ramon, (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact